caffeine and du-21220
caffeine has been researched along with du-21220 in 3 studies
Research
Studies (3)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Beaman, JH; Ejaz, K; Fedorowicz, Z; Jagannath, VA; Nasser, M; van Zuuren, EJ | 1 |
Reviews
1 review(s) available for caffeine and du-21220
| Article | Year |
|---|---|
Beta2-adrenoceptor agonists for dysmenorrhoea.
Topics: Acetaminophen; Adolescent; Adrenergic beta-2 Receptor Agonists; Adult; Caffeine; Dysmenorrhea; Female; Humans; Isoxsuprine; Metaproterenol; Randomized Controlled Trials as Topic; Ritodrine; Terbutaline; Young Adult | 2012 |
Other Studies
2 other study(ies) available for caffeine and du-21220
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |